| Chinese | English |
| 中剂量阿糖胞苷-米托蒽醌方案 | intermediate-dose Ara-C and mitoxan-trone (化疗方案) |
| 减量 BEAM 方案 | BCNU, etoposide, Ara-C and melphalan (由卡莫司汀、依托泊苷、阿糖胞苷及美法仑组成；抗肿瘤药) |
| 奥沙利铂-卡培他滨方案 | XELOX regimen (抗结直肠癌化疗方案) |
| 斯坦福大学方案V | Stanford V (由多柔比星、氮芥、长春碱、长春新碱、博来霉素、依托泊苷及泼尼松组成；化疗方案) |
| AC 方案 | adriamycin and cyclophosphamide (由阿霉素和环磷酰胺组成；化疗方案) |
| ACVBP 方案 | adriamycin, cyclophosphamide, vindesine, bleomycin and prednisone (由多柔比星、环磷酰胺、长春地辛、博来霉素、泼尼松及甲氨蝶吟组成；抗肿瘤药) |
| B-CAVe 方案 | bleomycin, CCNU, adriamycin and vinblastine (由博来霉素、洛莫司汀、多柔比星及长春花碱组成；化疗方案) |
| B-COPP 方案 | bleomycin, cyclophosphamide, vincristine, procarbazine and prednisone (由博来霉素、环磷酰胺、长春新碱、丙卡巴肼及泼尼松组成；化疗方案) |
| B-VIP 方案 | boanmycin, vincristine, ifosfamide and prednisone (由博安霉素、长春新碱、异环磷酰胺及泼尼松组成；化疗方案) |
| CAV 方案 | cyclophosphamide, adriamycin and vincristine (由环磷酰胺、多柔比星及长春新碱组成；抗肿瘤药) |
| CDOP 方案 | cyclophosphamide, doxorubicin, vincristine and prednisone (由环磷酰胺、脂质体多柔比星、长春新碱及泼尼松组成；化疗方案) |
| CEPP 方案 | cyclophosphamide, etoposide, procarbazine and prednisone (由环磷酰胺、依托泊苷、丙卡巴肼及泼尼松组成；化疗方案) |
| CHOP 方案 | cyclophosphamide, hydroxydaunomycin, oncovin and prednisone (由环磷酰胺、多柔比星、长春新碱及泼尼松组成；化疗方案) |
| CHOP-E 方案 | cyclophosphamide, hydroxydaunomycin, oncovin ,prednisone and etoposide (由环磷酰胺、多柔比星、长春新碱、泼尼松及依托泊苷组成；化疗方案) |
| CIBO-P方案 | lomustine, ifosfamide, bleomycin, vincristine and cisplatin (由洛莫司汀、异环磷酰胺、博来霉素、长春新碱及顺铂组成；化疗方案) |
| C-MOPP 方案 | cyclophosphamide, mechlorethamine, oncovin, procarbazine and prednisone (由环磷酰胺、氮芥、长春新碱、丙卡巴肼及泼尼松组成；化疗方案) |
| CODAP 方案 | cyclophosphamide, vincristine, daunorubicin, Ara-C and dexamethasone (由环磷酰胺、长春新碱、阿糖胞苷及地塞米松组成；化疗方案) |
| COP 方案 | cyclophosphamide, oncovin and prednisone (由环磷酰胺、长春新碱及泼尼松组成；化疗方案) |
| COPP 方案 | cyclophosphamide, oncovin, procarbazine and prednisone (由环磷酰胺、长春新碱、丙卡巴肼及泼尼松组成；化疗方案) |
| CTEP 方案 | cyclophosphamide, THP, etoposide and PDD (由环磷酰胺、吡柔比星、足叶乙苷及顺铂组成；化疗方案) |
| CVB 方案 | cyclophosphamide, VP-16 and BCNU (由环磷酰胺、依托泊苷及卡莫司汀组成；化疗方案) |
| CVPP 方案 | cyclophosphamide, vincristine, procarbazine and prednisone (由环磷酰胺、长春新碱、丙卡巴肼及泼尼松组成；化疗方案) |
| dex-BEAM 方案 | dexamethasone, BCNU, etoposide, Ara-C and melphalan (由地塞米松、卡莫司汀、依托泊苷、阿糖胞苷及美法仑组成；化疗方案) |
| DT-PACE 方案 | dexamethasone, thalidomide, PDD, adriamycin,cyclophosphamide and etoposide (由地塞米松、沙利度胺、多柔比星、环磷酰胺及依托泊苷组成；化疗方案) |
| EPOCH 方案 | etoposide, prednisone, oncovin, cyclophosphamide and hydroxydaunomycin (由依托泊苷、泼尼松、长春新碱、环磷酰胺及多柔比星组成；化疗方案) |
| FC 方案 | fludarabine and cyclophosphamide (由氟达拉滨和环磷酰胺组成；化疗方案) |
| FLAG 方案 | fludarabine, Ara-C and G-CSF (由氟达拉滨、阿糖胞苷及非格司亭组成；化疗方案) |
| GDP 方案 | gemcitabine, dexamethasone and PDD (由吉西他滨、地塞米松及顺铂组成；化疗方案) |
| IAE 方案 | idarubicin,Ara-C and etoposide (由伊达比星、阿糖胞苷及依托泊苷组成；化疗方案) |
| IGVP 方案 | ifosfamide, gemcitabine, vinorelbine and prednisone (由异环磷酰胺、吉西他滨、长春瑞滨及泼尼松组成；化疗方案) |
| IVAC 方案 | ifosfamide, vepesid, amethopterin and cytrabine (由异环磷酰胺、依托泊苷、甲氨蝶呤及阿糖胞苷组成；化疗方案) |
| LD 方案 | lenalidomide and dexamethasone (由来那度胺和地塞米松组成；化疗方案) |
| LMP 方案 | lenalidomide, melphalan and prednisone (由来那度胺、美法兰及泼尼松组成；化疗方案) |
| MAC0P-B 方案 | methotrexate, adriamycin, cyclophosphamide, oncovin,prednisone and bleomycin (由甲氨蝶呤、多柔比星、环磷酰胺、长春新碱、泼尼松、博来霉素及四氢叶酸钙组成；化疗方案) |
| MEA 方案 | mitoxantrone, etoposide and Ara-C (由米托蒽醌、依托泊苷及阿糖胞苷组成；化疗方案) |
| MIME 方案 | mitoguazone, ifosfamide, methotrexate and etoposide (由米托胍腙、异环磷酰胺、甲氨蝶呤及依托泊苷组成；化疗方案) |
| MOEP 方案 | methotrexate, oncovin, etoposide and prednisone (由米托蒽醌、长春新碱、依托泊苷及泼尼松组成；化疗方案) |
| MPT 方案 | melphalan, prednisone and thalidomide (由美法兰、泼尼松及沙利度胺组成；化疗方案) |
| MVC 方案 | methotrexate, vincristin and cisplatin (由氨甲蝶呤、长春新碱及顺铂组成；化疗方案) |
| OAP 方案 | oncovin, Ara-C and prednisone (由长春新碱、阿糖胞苷及泼尼松组成；化疗方案) |
| PCAB 方案 | prednisone, cyclophosphamide, adriamycin and BCNU (由泼尼松、环磷酰胺、多柔比星及卡莫司汀组成；化疗方案) |
| PET 方案 | paclitaxel, etoposide and cisplatin (由紫杉醇、足叶乙苷、顺铂及重组人粒细胞集落刺激因子组成；化疗方案) |
| POD 方案 | prednisone, oncovin and adriamycin (由泼尼松、硫酸长春新碱及盐酸多柔比星组成；化疗方案) |
| RCHOP 方案 | rituximab, cyclophosphamide, hydroxydaunomycin, oncovin and prednisone (由利妥昔单抗、环磷酰胺、阿霉素、长春新碱及泼尼松组成；化疗方案) |
| TAD 方案 | 6-thioguanine, ara-c and daunomycin (由6-硫鸟嘌呤、阿糖胞苷及柔红霉素组成；化疗方案) |
| TDD 方案 | thalidomide ； liposome doxorubicin and dexamethasone (由沙利度胺、脂质体多柔比星及地塞米松组成；化疗方案) |
| VCA 方案 | vincristine, dactinomycin and cyclophosphamide (由长春新碱、放线菌素D及环磷酰胺组成；化疗方案) |
| VACOP-B 方案 | vepeside, adriamycin, cyclophosphamide, oncovin ,prednisone and bleomycin (由依托泊苷、多柔比星、环磷酰胺、长春新碱、泼尼松及博来霉素组成；化疗方案) |
| VAEP 方案 | vincristine, Ara-C, etoposide and prednisone (由长春新碱、阿糖胞苷、依托泊苷及泼尼松组成；化疗方案) |
| VBAP 方案 | vincristine, BCNU, adriamycin and prednisone (由长春新碱、卡莫司汀、多柔比星及泼尼松组成；化疗方案) |
| VM 方案 | velcade and melphalan (由硼替佐米和美法兰组成；化疗方案) |
| VT 方案 | velcade and thalidomide (由硼替佐米和沙利度胺组成；化疗方案) |
| VTD 方案 | velcade, thalidomide and dexamethasone (由硼替佐米、沙利度胺及地塞米松组成；化疗方案) |
| VMP 方案 | velcade, melphalan and prednisone (由硼替佐米、美法兰及泼尼松组成；化疗方案) |
| VD 方案 | velcade and dexamethasone (由硼替佐米和地塞米松组成；化疗方案) |
| VAMP 方案 | vincristin, methotrexate, 6 -mercaptopurine and prednisone (由长春新碱、甲氨蝶呤、6-巯基嘌呤及泼尼松组成；化疗方案) |
| VAD 方案 | vincristine, adriamycin and dexamethasone (由长春新碱、多柔比星及地塞米松组成；化疗方案) |
| VACD 方案 | vincristine, adriamycin, cyclophosphamide and dexamethasone (由长春新碱、多柔比星、环磷酰胺及地塞米松组成；化疗方案) |
| TP 方案 | thalidomide and dexamethasone (由沙利度胺及地塞米松组成；化疗方案) |
| TD 方案 | thalidomide and dexamethasone (由沙利度胺及地塞米松组成；化疗方案) |
| SMILE 方案 | surodex, methotrexate, ifosfamide, L-asparaginase and etoposide (由地塞米松、米托蒽醌、异环磷酰胺、左旋门冬酰胺酶及依托泊苷组成；化疗方案) |
| POMP 方案 | prednisone, oncovin, methotrexate and 6-mercaptopurine (由泼尼松、长春新碱、甲氨蝶呤及6-巯嘌呤组成；化疗方案) |
| PmM 方案 | prednimustine and mitoxantrone (由泼尼莫司汀及米托蒽醌组成；化疗方案) |
| PEDA 方案 | PDD, etoposide, dexamethasone and Ara-C (由顺铂、依托泊苷、地塞米松及阿糖胞苷组成；化疗方案) |
| OFAR 方案 | oxaliplatin, fludarabine, Ara-C and rituximab (由奥沙利铂、氟达拉滨、阿糖胞苷及利妥昔单抗组成；化疗方案) |
| MOPP 方案 | mechlorethamine, vincristine, procarbazine and prednisone (由氮芥、长春新碱、丙卡巴肼及泼尼松组成；化疗方案) |
| MVAC 方案 | methotrexate, vincristin, doxorubicin and cisplatin (由氨甲蝶呤、长春新碱、多柔比星及顺铂组成；化疗方案) |
| MOPP 方案 | mechlorethamine, oncovin, procarbazine and prednisone (由氮芥、长春新碱、丙卡巴肼及泼尼松组成；化疗方案) |
| MINE 方案 | mesna, ifosfamide, novantrone and etoposide (由美司钠、异环磷酰胺、米托蒽醌及依托泊苷组成；化疗方案) |
| MIE 方案 | mitoxantrone, ifosfamide and etoposide (由米托蒽醌、异环磷酰胺及依托泊苷组成；化疗方案) |
| M-BACOD 方案 | methotrexate, bleomycin, adriamycin, cyclophosphamide ,oncovin and dexamethasone (由甲氨蝶呤、博来霉素、多柔比星、环磷酰胺、长春新碱、泼尼松及四氢叶酸钙组成；化疗方案) |
| LOPP 方案 | leukeran, oncovin, procarbazine and prednisone (由苯丁酸氮芥、长春新碱、丙卡巴肼及泼尼松组成；化疗方案) |
| LDVD 方案 | lenalidomide and liposomal doxorubicin, vincristine and dexamethasone (由来那度胺、多柔比星脂质体、长春新碱及地塞米松组成；化疗方案) |
| IVE 方案 | ifosfamide, vepesid and epirubicin (由异环磷酰胺、依托泊苷及表柔比星组成；化疗方案) |
| IMVP-16方案 | ifosfamide, methotrexate and etoposide (由异环磷酰胺、甲氨蝶呤及依托泊苷组成；化疗方案) |
| ICE 方案 | ifosfamide, carboplatin and etoposide (由异环磷酰胺、卡铂及依托泊苷组成；化疗方案) |
| HOP 方案 | hydroxydaunomycin, oncovin and prednisone (由多柔比星、长春新碱及泼尼松组成；化疗方案) |
| FMD 方案 | fludarabine, mitoxantrone and dexamethasone (由氟达拉滨、米托蒽醌及地塞米松组成；化疗方案) |
| FCM 方案 | fludarabine, cyclophosphamide and mitoxantrone (由氟达拉滨、环磷酰胺及米托蔥醌组成；化疗方案) |
| FA 方案 | fludarabine and Ara-C (由氟达拉滨和阿糖胞苷组成；化疗方案) |
| EPIC 方案 | etoposide, prednisone, ifosfamide and cisplatin (由依托泊苷、泼尼松、异环磷酰胺及顺铂组成；化疗方案) |
| DICE 方案 | dexamethasone, ifosfamide, cisplatin and etoposide (由地塞米松、异环磷酰胺、顺铂及依托泊苷组成；化疗方案) |
| DCEP 方案 | dexamethasone, cyclophosphamide, etoposide and PDD (由地塞米松、环磷酰胺、依托泊苷及顺铂组成；化疗方案) |
| CVB 方案 | CCNU,vinblastine and bleomycin (由洛莫司汀、长春碱及博莱霉素组成；化疗方案) |
| CVP 方案 | cyclophosphamide, vincristine and prednisone (由环磷酰胺、长春新碱及泼尼松组成；化疗方案) |
| CTD 方案 | cyclophosphamide, thalidomide and dexamethasone (由环磷酰胺、沙利度胺及地塞米松组成；化疗方案) |
| COP-BLAM 方案 | cyclophosphamide, oncovin, prednisone, bleomycin, adriamycin and matulane (由环磷酰胺、长春新碱、泼尼松、博莱霉素、阿霉素及丙卡巴肼组成；化疗方案) |
| COMP 方案 | cyclophosphamide, vincristine, methotrexate and prednisone (由环磷酰胺、长春新碱、甲氨蝶呤及泼尼松组成；化疗方案) |
| CMOP 方案 | cyclophosphamide, mitoxantrone, oncovin and prednisone (由环磷酰胺、米托蒽醌、长春新碱及泼尼松组成；化疗方案) |
| CMF 方案 | cyclophosphamide ； methotrexate and 5-fluorouracil (由环磷酰胺、甲氨蝶呤及5-氟尿嘧啶组成；化疗方案) |
| CHOP-L-ASP 方案 | CHOP-L-ASP (cyclophosphamide, hydroxydaunomycin, oncovin, prednisone and L-asparaginase 的 缩写, 由环磷酰胺、多柔比星、长春新碱、泼尼松及门冬酰胺酶组成；化疗方案) |
| CHOP-Bleo 方案 | cyclophosphamide, hydroxydaunomycin, oncovin ,prednisone and bleomycin (由环磷酰胺、多柔比星、长春新碱、泼尼松及博来霉素组成；化疗方案) |
| CHLVPP 方案 | chlorambucil, vincristine, procarbazine and prednisone (由苯丁酸氮芥、长春新碱、丙卡巴胂及泼尼松组成；化疗方案) |
| CEOP 方案 | cyclophosphamide, etoposide, oncovin and prednisone (由环磷酰胺、依托泊苷、长春新碱及泼尼松组成；化疗方案) |
| CDEOP 方案 | cyclophosphamide, DDP cisplatin , etoposide, vincristine and prednisone (由环磷酰胺、顺铂、依托泊苷、长春新碱及泼尼松组成；化疗方案) |
| CAG 方案 | cytrabine, aclarubicin and G-CSF (由阿糖胞苷、阿柔比星及非格司亭组成；化疗方案) |
| BEACOPP 方案 | bleomycin, etoposide, adriamycin, cyclophosphamide ,vincristine, procarbazine and prednisone (由博来霉素、依托泊苷、多柔比星、环磷酰胺、长春新碱、甲基苄肼及泼尼松组成；化疗方案) |
| BCHOP 方案 | bleomycin, cyclophosphamide, vincristine, adriamycin and prednisone (由博来霉素、环磷酰胺、长春新碱、多柔比星及泼尼松组成；化疗方案) |
| BACOP 方案 | bleomycin, adriamycin, cyclophosphamide, vincristine and prednisone (由博来霉素、多柔比星、环磷酰胺、长春新碱及泼尼松组成；抗肿瘤药) |
| ACM 方案 | adriamycin, cyclophosphamide and methotrexate (由阿霉素、环磷酰胺及甲氨蝶呤组成；化疗方案) |
| ABVD 方案 | adriamycin, bleomycin, vinblastine and dacarbazine (由多柔比星、博来霉素、长春花碱及达卡巴嗪组成；化疗方案) |
| ABCM 方案 | adriamycin, BCNU, cyclophosphamide and melphalan (由多柔比星、卡莫司汀、环磷酰胺及美法仑组成；化疗方案) |
| ABCD 方案 | adriamycin, bleomycin, CCNU and dacarbazine (由多柔比星、博来霉素、洛莫司汀及达卡巴嗪组成；化疗方案) |
| 来那度胺-利妥昔单抗方案 | lenalidomide and rituximab (化疗方案) |
| 高强度 CVAD 方案 | hyper cyclophosphamide, vincristine, adriamycin and dexamethasone (由环磷酰胺、长春新碱、多柔比星、地塞米松及美司钠组成；化疗方案) |
